Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility

Yana Roka-Moiia, Mengtang Li, Adriana Ivich, Sami Muslmani, Karl B. Kern, Marvin J. Slepian

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Despite growing use of mechanical circulatory support, limitations remain related to hemocompatibility. Here, we performed a head-to-head comparison of the hemocompatibility of a centrifugal cardiac assist system - the Centrimag, with that of the latest generation of an intravascular microaxial system - the Impella 5.5. Specifically, hemolysis, platelet activation, microparticle (MP) generation, and von Willebrand factor (vWF) degradation were evaluated for both devices. Freshly obtained porcine blood was recirculated within device propelled mock loops for 4 hours, and alteration of the hemocompatibility parameters was monitored over time. We found that the Impella 5.5 and Centrimag exhibited low levels of hemolysis, as indicated by minor increase in plasma free hemoglobin. Both devices did not induce platelet degranulation, as no alteration of β-thromboglobulin and P-selectin in plasma occurred, rather minor downregulation of platelet surface P-selectin was detected. Furthermore, blood exposure to shear stress via both Centrimag and Impella 5.5 resulted in a minor decrease of platelet count with associated ejection of procoagulant MPs, and a decrease of vWF functional activity (but not plasma level of vWF-antigen). Greater MP generation was observed with the Centrimag relative to the Impella 5.5. Thus, the Impella 5.5 despite having a lower profile and higher impeller rotational speed demonstrated good and equivalent hemocompatibility, in comparison with the predicate Centrimag, with the advantage of lower generation of MPs.

Original languageEnglish (US)
Pages (from-to)1142-1151
Number of pages10
JournalASAIO Journal
Issue number10
StatePublished - Nov 1 2020


  • Centrimag
  • Impella 5.5
  • device hemocompatibility
  • hemolysis
  • mechanical circulatory support
  • microparticles
  • platelet activation
  • von Willebrand factor degradation

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering


Dive into the research topics of 'Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility'. Together they form a unique fingerprint.

Cite this